Network Design, Access, and Steerage
The Invisible Hand That Determines What Your Rates Are Actually Worth
Network design is the payer's most powerful non-price lever and the provider's most significant competitive concern. How members are steered determines the real economic value of any rate agreement.
The Rate That Doesn't Matter
Here is a negotiation truth that takes most provider executives years to learn: a rate means nothing without volume.
300% of Medicare
Applied to zero patients = zero revenue
180% of Medicare
With guaranteed preferred-tier steerage + 40,000 attributed lives = career-defining partnership
Yet most provider negotiation teams spend 80% of their preparation time on rates and 20% on network design. The Architect inverts this ratio — because network design is the mechanism through which rates become revenue.
Network Type and Exclusivity
The network model determines the fundamental economic relationship between rates, volume, and member choice.
Broad PPO Networks
Large, open networks including majority of providers in a market. Members self-refer to any in-network provider with modest cost-sharing differentials.
Economics:
Lowest volume commitment to any individual provider. Payer has minimal steerage leverage — members go where they choose. Volume reflects historical patterns, reputation, geographic convenience.
Prevalence:
2025: PPO plans averaged $9,818 single coverage, $28,272 family — highest premiums among plan types, reflecting cost of broad access.
Provider Strategic Implication:
Baseline revenue but limited growth opportunity. Rate increases rarely translate to volume increases because no steerage commitment. Treat as floor revenue.
Narrow/Select Networks
Restricted networks including 30-70% of market providers. Members have limited choices but benefit from lower premiums.
Economics:
Creates volume-rate trade-off. By limiting network, payer concentrates volume among fewer providers — creating leverage for lower rates while offering higher volume.
Prevalence:
2025: 8% of firms 50+ employees offered narrow network (17% for firms 5,000+ employees). Reduces premiums 5-15% while concentrating volume.
Provider Strategic Implication:
High-stakes: Inclusion = lower rates + guaranteed volume. Exclusion = lose entire patient population. Profitable only if volume commitment enforceable and rate reduction calibrated to marginal cost, not average cost.
Exclusive Provider Organizations (EPOs)
Narrowest commercial network. Members must use network providers except emergencies — no out-of-network benefit. Functionally an HMO without gatekeeper.
Economics:
Maximum steerage because members have no choice. Generates maximum volume commitment to included providers — and maximum pressure on rates.
Prevalence:
Growing in employer-sponsored plans seeking to balance cost control with gatekeeper elimination.
Provider Strategic Implication:
EPO inclusion at competitive rate = extremely profitable (guaranteed volume). EPO exclusion = catastrophic (lose 100% of covered population with no OON spillover).
Tiered Networks
All providers remain in-network, but members face different cost-sharing by tier. Preferred-tier = lowest cost-sharing; standard = higher; non-preferred = highest.
Economics:
Harvard/Commonwealth Fund: BCBS MA tiered plans — $170/admission preferred tier, $360 middle tier, $1,070 non-preferred. UPenn research: tiered networks generate 12% total savings (1-8% steerage + 2-4% negotiated price reductions).
Prevalence:
2025: 15% of firms 50+ employees (24% for firms 5,000+ workers). Growing — payer's preferred steerage tool preserving member choice while creating price-quality incentives.
Provider Strategic Implication:
Tier placement is most consequential non-rate provision. Tier 1 vs. Tier 2 = 10-30% volume differential for new patients — worth far more than 2-3% rate differential. Negotiate tier criteria, tier mobility, tier transparency.
High-Performance Networks / Centers of Excellence
Curated subset of providers selected on quality, cost, outcomes for specific conditions. Members receive enhanced benefits (waived deductibles, reduced copays, travel subsidies) when using COE.
Economics:
COE designations concentrate high-acuity, high-revenue cases. Joint replacement COE for national employer may receive referrals across country — each representing $30K-$60K revenue at bundled rates lower than local market but extremely profitable on marginal-cost basis.
Prevalence:
Common COE designations: Joint replacement, spine surgery, bariatric, cardiac, transplant, oncology, maternity.
Provider Strategic Implication:
COE status = volume concentration of highest-revenue cases. Requires demonstrable quality outcomes, willingness to accept bundled pricing, operational capacity for geographic patient influx.
Steerage Mechanisms
Network design creates the structure for steerage. These mechanisms create the force that moves patients toward preferred providers.
Benefit Design Steerage
Most powerful steerage mechanism — controlling member cost-sharing to create financial incentives for provider selection.
Examples:
- Copay differentials: $20 preferred-tier PCP vs. $40 standard vs. $75 non-preferred
- Coinsurance differentials: 10% preferred vs. 30% standard vs. 50% non-preferred
- Deductible differentials: $500 preferred vs. $2,000 standard vs. $5,000 non-preferred
- OOP maximum differentials: Separate, lower OOP max for preferred-tier utilization
Principle:
Steerage gradient principle: Effectiveness proportional to cost-sharing differential. $5 copay difference = negligible. $50 = meaningful. $500 deductible difference = powerful. Activation threshold: $200-500 per episode differential produces meaningful behavior change.
Prior Authorization and Referral Requirements
Administrative steerage — requiring payer approval before accessing certain providers or services.
Examples:
- Referral requirements: PCP must authorize specialist access (traditional HMO; declining popularity)
- Prior authorization for facilities: Payer must approve inpatient admission, outpatient surgery facility, high-cost imaging
- Site-of-service authorization: Payer requires services at lowest-cost appropriate setting (ASC over HOPD, office over hospital)
- Network-specific authorization: Prior auth waived for preferred-tier providers, required for others
Principle:
Creates friction for non-preferred utilization while smoothing path for preferred providers. Effectiveness depends on administrative burden differential.
Care Navigation and Concierge Programs
Soft steerage through guidance rather than financial penalties.
Examples:
- Nurse navigators: Plan-employed nurses guide members to preferred providers based on condition, quality, cost
- Concierge programs: Dedicated member advocates schedule appointments, coordinate referrals, recommend specific providers
- Decision support tools: Digital platforms show quality ratings, cost estimates, provider recommendations
- Care pathways: Condition-specific treatment protocols route patients through preferred provider sequences
Principle:
Relies on trust and convenience rather than penalties. Most effective for complex, high-cost episodes where members actively seek guidance.
Digital-First Pathways
Emerging steerage through technology.
Examples:
- Virtual-first plans: Members access virtual primary care as default; in-person referrals directed to preferred network
- App-based provider selection: Health plan apps surface preferred providers with prominent placement, positive ratings, streamlined scheduling
- AI-powered recommendations: Algorithms recommend specific providers based on member condition, location, plan design, provider quality data
Principle:
Leverages digital convenience and information asymmetry. Members follow path of least resistance — which is architected to preferred providers.
Employer-Sponsored Steerage Programs
Direct employer intervention in provider selection.
Examples:
- Reference pricing: Employer sets maximum contribution (e.g., $30K for hip replacement); member pays difference at higher-cost providers
- COE mandates: Employer requires specific high-cost procedures at designated COE providers — with travel and lodging benefits
- Navigation incentives: Cash bonuses or reduced cost-sharing for members using employer-designated navigation services before elective procedures
- On-site clinics: Employer-operated or contracted primary care clinics function as gatekeepers to broader network
Principle:
Most powerful steerage — employer has strongest financial incentive and least regulatory constraint. Reference pricing creates intense price transparency and drives volume to lower-cost providers.
Restrictive Contract Clauses
Restrictive contract clauses are the legal mechanisms through which dominant payers or dominant providers limit competition and protect market position. They are the most scrutinized — and most strategically consequential — provisions in any network contract.
Most Favored Nation (MFN) Clauses
Contractual guarantee from provider that payer will receive rates equal to or better than rates offered to any other payer.
Types:
- • Broad MFN: Provider guarantees payer its lowest rate across all payers (commercial, government, self-funded)
- • Narrow MFN: Lowest rate among commercial payers only (excluding Medicare/Medicaid)
- • MFN-plus: Rates lower than any other payer (e.g., "5% below lowest rate offered to any other commercial payer")
Anticompetitive Effects:
When dominant payer holds MFN, provider discouraged from offering discounts to competing payers — every discount to competitor must be given to MFN holder. Raises rivals' costs. DOJ challenged BCBS Michigan MFN clauses, alleging they raised hospital prices 10-23%.
Legal Status:
18 states enacted MFN bans: AK, CT, GA, HI, IN, ME, MD, MA, MN, MT, NH, NY, OH, RI, SD, VT, WA, WV. Not per se illegal but subject to rule-of-reason antitrust analysis.
Negotiation Implications:
Provider: Accepting MFN constrains rate flexibility with every other payer. Model impact on all payer contracts — 2% rate reduction to one payer could cascade through MFN clauses to reduce revenue across entire commercial book. Payer: MFN increasingly legally risky even in states without explicit bans.
All-Products Clauses
Requirement that provider participate in ALL of payer's plan products (broad PPO, narrow network, HMO, EPO, MA, Medicaid managed care) as condition of participating in any.
Anticompetitive Effects:
Hospital systems often use inverse — "all-or-nothing" clauses requiring payer contract with all affiliated facilities (including high-cost AMCs) as condition of accessing any. Council for Affordable Health Coverage urged DOJ to ban such clauses as mechanism "immunizing conglomerate from price competition".
Strategic Impact:
Forces participation in low-margin or money-losing products (typically Medicaid managed care or narrow network plans with deeply discounted rates). Binary choice: participate in everything or lose entire payer relationship.
Negotiation Implications:
Provider: Negotiate product-specific rate differentials. Accept all-products participation but with rates calibrated to each product's economics — not single rate applied across products with vastly different demographics, utilization patterns, administrative requirements.
Anti-Steering Clauses
Contract provisions prohibiting payer from steering members away from provider through narrow networks, tiered networks, differential cost-sharing, or educational materials.
Landmark Case:
DOJ's 2016-2018 case against Atrium Health (formerly Carolinas HealthCare System): Atrium, dominant Charlotte hospital system, used anti-steering provisions to prevent insurers from creating narrow or tiered networks directing patients to lower-cost competitors. DOJ found Atrium's prices higher than competitors — "not explained by any measure of quality" — and anti-steering clauses insulated these prices from competition.
Settlement:
Atrium prohibited from enforcing existing anti-steering clauses, barred from seeking such provisions in future contracts, subjected to 10 years of Antitrust Division oversight. DOJ noted anti-steering clauses "curbed introduction of innovative healthcare plans" and "reduced choices for Charlotte-area consumers".
Post-Atrium Landscape:
Settlement established that anti-steering clauses imposed by dominant providers are presumptively anticompetitive. DOJ Statement of Interest in subsequent Sutter Health case in California extended this principle. Providers using anti-steering clauses in concentrated markets face increasing litigation risk.
Negotiation Implications:
Provider: Rather than demanding blanket anti-steering protection (legally risky, operationally limiting), negotiate tier criteria that are transparent, quality-based, performance-linked. If tier placement determined by objective quality and cost metrics — and provider exceeds those metrics — preferred placement follows automatically.
Anti-Tiering Clauses
Provisions preventing payer from placing provider in non-preferred tier — requiring provider be placed in lowest cost-sharing (most preferred) tier.
Negotiation Implications:
Architect's approach: Rather than demanding blanket anti-tiering protection (legally risky, operationally limiting), negotiate tier criteria that are transparent, quality-based, performance-linked.
Gag Clauses
Provisions restricting provider or payer from sharing price, quality, or cost information with patients, employers, or public.
Negotiation Implications:
Both sides should resist gag clauses beyond legitimate trade secret protection. Transparency serves long-term market efficiency even when it creates short-term competitive discomfort.
The Site-of-Service Reality
Site-of-service is among the most financially consequential battlegrounds in contemporary payer/provider negotiations — driven by the stark reality that Medicare pays 2-4 times more for many identical outpatient procedures when performed in a hospital outpatient department (HOPD) rather than a physician's office.
Payment Differentials:
• Level 5 E/M visit: ~$160 office vs. ~$310 HOPD (94% differential)
• Echocardiogram: ~$190 office vs. ~$450 HOPD (137% differential)
• Colonoscopy: ~$450 office vs. ~$1,100 HOPD (144% differential)
• Cataract surgery: ~$1,000 ASC vs. ~$1,900 HOPD (90% differential)
The Site-Neutrality Revolution:
CBO estimates that eliminating Medicare Part B payment differential between HOPDs and physician practices for lower-acuity services could save $157 billion over 10 years — making site-neutrality one of the largest potential savings in the entire Medicare program.
CY 2026 OPPS Final Rule: CMS expanded site-neutral payment to drug administration services at grandfathered off-campus HOPDs, paying the site-neutral rate of 40% of OPPS — estimated to cut OPPS spending by $290M in 2026 alone.
Your Network Strategy Analysis
Map your current network positioning across your major payer relationships. For each payer: What network type? What tier placement (if tiered)? What steerage mechanisms are active? What is your estimated volume share relative to competitors? Calculate: Net Revenue Impact = (Rate × Volume with current network design) vs. (Alternative Rate × Volume with alternative network design).
A 5% rate increase is worth less than preferred-tier placement that delivers a 15% volume increase.
Your Restrictive Clauses Audit
Audit your current contracts for restrictive clauses. For each: (1) Identify which clauses exist (MFN, all-products, anti-steering, anti-tiering, gag), (2) Assess legal risk (especially in 18-state MFN ban jurisdictions), (3) Calculate financial impact (e.g., MFN cascade across other payers, all-products forcing low-margin product participation), (4) Develop negotiation strategy (eliminate, narrow scope, or negotiate offsetting value).
Practice What You Just Learned
Don't just read about the negotiation crisis — step into it. These exercises turn the chapter's concepts into lived experience using your AI negotiation partners.
Negotiate Rate vs. Volume
The chapter's central insight: a rate means nothing without volume. 300% of Medicare applied to zero patients equals zero revenue; 180% of Medicare with guaranteed preferred-tier steerage equals a career-defining partnership. In this exercise, the Sparring Partner plays a payer offering an attractive rate increase while quietly gutting the value through network design: broad PPO placement with no steerage, tiered network placement in the non-preferred tier, an MFN clause that prevents competitive discounting, an all-products clause forcing money-losing participation, and site-of-service restrictions. You'll need to shift the conversation from rate to volume, calculate Net Revenue Impact, and negotiate tier criteria, steerage, and restrictive clause terms.
What You'll Experience
- Shift negotiation focus from rate to Rate × Volume (Net Revenue Impact)
- Negotiate tier placement, steerage mechanisms, and volume commitments
- Identify and counter restrictive clauses that silently transfer value
- Trade rate concessions for volume guarantees where the math supports it
Design Your Network Strategy
The chapter provides five network types, five steerage mechanisms, five restrictive clause categories, and the site-of-service reality. Now use The Architect to apply all of it to your actual payer relationships — map your current network positioning, calculate Net Revenue Impact under alternative designs, negotiate tier criteria and steerage mechanisms, audit restrictive clauses for legal and financial impact, and develop a strategy that trades rate for volume where the math supports it. This is where rates become revenue.
What You'll Experience
- Map current network positioning across all major payer relationships
- Calculate Net Revenue Impact under alternative network design scenarios
- Design tier criteria and steerage mechanisms that create mutual value
- Audit restrictive clauses for legal risk and financial cascade impact